Quote Level 2 Charts News Trades Historical Financials Wiki Market In 3D Message Board

Delcath Systems, Inc. (DCTH)

$ 0.4101 ▲0.0001 (0.02%)
Volume: 207,088
Add DCTH To StreamerAdd DCTH To Streamer
Add DCTH To My StocksAdd DCTH To My Stocks
Add DCTH Price AlertAdd DCTH Price Alert
Bid Ask Last Traded Open Prev Close
0.37 18.68 4:00:00 PM EST 0.392 0.41
Day's Range 52-Wk Range Avg Volume EPS P/E
0.392 - 0.4198 0.36 - 2.78 571,883 -1.84 N/A
Market Cap Outstanding Float Dividend / Yield Ex-Div Date
10 21.76M 12.13M N/A N/A
Short Interest Short % of Float Insider B/S Inst % Owned Exchange
447,452 3.69 % N/A 18 % NASDAQ
Support 2 Support 1 Pivot Price Resistance 1 Resistance 2
$ 0.3795 $ 0.3948 $ 0.4073 $ 0.4226 $ 0.4351
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
Edgar (US Regulatory) • Fri Aug 14,2015 4:31 PM
Current Report Filing (8-k)
Edgar (US Regulatory) • Fri Aug 14,2015 4:08 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
Edgar (US Regulatory) • Mon Aug 10,2015 5:14 PM
Quarterly Report (10-q)
Edgar (US Regulatory) • Wed Aug 5,2015 4:39 PM
Delcath Reports 2015 Second Quarter Financial Results
PR Newswire (US) • Wed Aug 5,2015 8:00 AM
Delcath Announces Acceptance of Abstracts for Presentation at the European Association of Dermato Oncology Annual Congress
PR Newswire (US) • Tue Aug 4,2015 8:00 AM
Statement of Changes in Beneficial Ownership (4)
Edgar (US Regulatory) • Tue Jul 28,2015 5:06 PM
Statement of Changes in Beneficial Ownership (4)
Edgar (US Regulatory) • Tue Jul 28,2015 3:52 PM
Statement of Ownership (sc 13g)
Edgar (US Regulatory) • Mon Jul 27,2015 5:02 PM
Statement of Changes in Beneficial Ownership (4)
Edgar (US Regulatory) • Fri Jul 24,2015 4:58 PM
Statement of Changes in Beneficial Ownership (4)
Edgar (US Regulatory) • Wed Jul 22,2015 5:56 PM
Delcath Receives Orphan Drug Designation From FDA For Melphalan To Treat Cholangiocarcinoma
PR Newswire (US) • Mon Jul 20,2015 8:00 AM
Link to Delcath Stock Price

Delcath Systems, Inc. Company Description


Delcath Systems, Inc., is a pharmaceutical and medical device company. It focuses on the treatment of primary and metastatic liver cancers. URL: http://www.delcath.com

DCTH Intraday Stock Chart

1d 1m 3m 6m 1y 2y 5y


DCTH vs ETF alternatives
ETFsToday3mths1YrYTD
DCTH0.02%-64.65%-82.70%-67.71%
SPY0.08%-6.36%-0.57%-2.81%
RWL0.18%-7.40%-1.27%-4.52%
PRF0.16%-7.94%-4.06%-5.54%
IPD1.16%-10.63%-3.46%0.56%
EPS0.17%-7.54%-2.82%-5.39%
XLY0.03%-1.65%9.78%5.46%
SSO0.15%-12.50%-50.48%-53.09%



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.